These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 31444171)
1. Erratum for DeMarco et al., "Determination of [ DeMarco VP; Ordonez AA; Klunk M; Prideaux B; Wang H; Zhang Z; Tonge PJ; Dannals RF; Holt DP; Lee CKK; Weinstein EA; Dartois V; Dooley KE; Jain SK Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31444171 [No Abstract] [Full Text] [Related]
2. Determination of [11C]rifampin pharmacokinetics within Mycobacterium tuberculosis-infected mice by using dynamic positron emission tomography bioimaging. DeMarco VP; Ordonez AA; Klunk M; Prideaux B; Wang H; Zhuo Z; Tonge PJ; Dannals RF; Holt DP; Lee CK; Weinstein EA; Dartois V; Dooley KE; Jain SK Antimicrob Agents Chemother; 2015 Sep; 59(9):5768-74. PubMed ID: 26169396 [TBL] [Abstract][Full Text] [Related]
3. ISONIAZID AND RIFAMPIN PHARMACOKINETICS IN TWO ASIAN ELEPHANTS (ELEPHAS MAXIMUS) INFECTED WITH MYCOBACTERIUM TUBERCULOSIS. Egelund EF; Isaza R; Alsultan A; Peloquin CA J Zoo Wildl Med; 2016 Sep; 47(3):868-871. PubMed ID: 27691967 [TBL] [Abstract][Full Text] [Related]
4. Murine Mycobacterium marinum Infection as a Model for Tuberculosis. Lienard J; Carlsson F Methods Mol Biol; 2017; 1535():301-315. PubMed ID: 27914088 [TBL] [Abstract][Full Text] [Related]
5. Assessing the Combined Antibacterial Effect of Isoniazid and Rifampin on Four Mycobacterium tuberculosis Strains Using Genestet C; Ader F; Pichat C; Lina G; Dumitrescu O; Goutelle S Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061753 [TBL] [Abstract][Full Text] [Related]
6. Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice. Vilchèze C; Kim J; Jacobs WR Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29298757 [TBL] [Abstract][Full Text] [Related]
7. Radiolabelling and positron emission tomography of PT70, a time-dependent inhibitor of InhA, the Mycobacterium tuberculosis enoyl-ACP reductase. Wang H; Liu L; Lu Y; Pan P; Hooker JM; Fowler JS; Tonge PJ Bioorg Med Chem Lett; 2015 Nov; 25(21):4782-4786. PubMed ID: 26227776 [TBL] [Abstract][Full Text] [Related]
8. The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin. Liang Y; Wu X; Zhang J; Li N; Yu Q; Yang Y; Bai X; Liu C; Shi Y; Liu Q; Zhang P; Li Z Vaccine; 2008 Aug; 26(35):4536-40. PubMed ID: 18602439 [TBL] [Abstract][Full Text] [Related]
9. Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages. Dhillon J; Mitchison DA Am Rev Respir Dis; 1992 Jan; 145(1):212-4. PubMed ID: 1309967 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice. Ji B; Truffot-Pernot C; Lacroix C; Raviglione MC; O'Brien RJ; Olliaro P; Roscigno G; Grosset J Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1541-6. PubMed ID: 8256897 [TBL] [Abstract][Full Text] [Related]
11. [Susceptibility test to rifampin by using quantitative analysis of Mycobacterium tuberculosis mRNA]. Lu Y; Zhu LZ; Chu NH; Duan LS; Liang GF Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):549-52. PubMed ID: 15388006 [TBL] [Abstract][Full Text] [Related]
12. [Characterization of rpoB mutation in rifampin - resistant clinical Mycobacterium tuberculosis isolates from China]. Huang H; Jin Q; Ma Y Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):231-5. PubMed ID: 11802970 [TBL] [Abstract][Full Text] [Related]
13. Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis? Alfarisi O; Alghamdi WA; Al-Shaer MH; Dooley KE; Peloquin CA Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1027-1036. PubMed ID: 28803492 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of clinical characteristics between rifampin-dependent and rifampin- resistant patients with pulmonary tuberculosis]. Li Y; Tan S; Luo C; Li Y; Qin H; Feng Z Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):287-9. PubMed ID: 23443791 [TBL] [Abstract][Full Text] [Related]
15. Computational pharmacokinetics/pharmacodynamics of rifampin in a mouse tuberculosis infection model. Lyons MA; Lenaerts AJ J Pharmacokinet Pharmacodyn; 2015 Aug; 42(4):375-89. PubMed ID: 26026426 [TBL] [Abstract][Full Text] [Related]
16. [Study on the sequences of amino-acids and their gene codes of the related proteins of rifampin-dependent Mycobacterium tuberculosis]. Zhong M; Wang YW; Hu PP; Bao JL; Zhong J; Hu ZY; Luo YA Zhonghua Jie He He Hu Xi Za Zhi; 2006 Feb; 29(2):83-6. PubMed ID: 16677447 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples. Gamboa F; Cardona PJ; Manterola JM; Lonca J; Matas L; Padilla E; Manzano JR; Ausina V Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):189-92. PubMed ID: 9665301 [TBL] [Abstract][Full Text] [Related]
18. Combination of anti-tuberculosis drugs with vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains. Khameneh B; Fazly Bazzaz BS; Amani A; Rostami J; Vahdati-Mashhadian N Microb Pathog; 2016 Apr; 93():83-7. PubMed ID: 26602814 [TBL] [Abstract][Full Text] [Related]
19. Assessment of Bactericidal Drug Activity and Treatment Outcome in a Mouse Tuberculosis Model Using a Clinical Beijing Strain. Mourik BC; de Knegt GJ; Verbon A; Mouton JW; Bax HI; de Steenwinkel JEM Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739784 [No Abstract] [Full Text] [Related]
20. Population pharmacokinetics of rifampin in the treatment of Mycobacterium tuberculosis in Asian elephants. Egelund EF; Isaza R; Brock AP; Alsultan A; An G; Peloquin CA J Vet Pharmacol Ther; 2015 Apr; 38(2):137-43. PubMed ID: 25236765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]